columba study update: subcutaneous daratumumab in r/r mm
Published 4 years ago • 224 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
4:59
columba: subcutaneous daratumumab vs. iv administration
-
2:39
subcutaneous daratumumab: an update on the latest mm clinical trials
-
3:48
subcutaneous daratumumab in r/r myeloma: the columba trial
-
4:07
trial updates in myeloma: columba and pollux
-
1:27
columba: sc vs iv daratumumab in r/r multiple myeloma
-
1:07:05
meliodosis - infectious diseases - copm weekly webinar 24
-
26:31
comprehensive management of sickle cell disease using hydroxyurea by dr. ruth namazzi
-
12:24
progress report iii - katalin martyin
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
1:48
cassiopeia: update on daratumumab maintenance for multiple myeloma
-
1:46
personalized treatments to manage post-transplantation outcomes in aml: insights from morpho
-
5:07
daratumumab in the management of al amyloidosis
-
1:28
campus all updates: the safety and efficacy of daratumumab for the treatment of all
-
0:52
phase i study of ft538, an ipsc-derived nk cell therapy, with daratumumab in r/r multiple myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
3:55
cassiopeia: analysis of daratumumab maintenance for myeloma
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
15:09
subcutaneous daratumumab — dr. jonathan kaufman | mcrt webcast july 11
-
4:30
andromeda: daratumumab for al amyloidosis
-
2:42
results from a phase i study of cc-98633 in r/r myeloma